Letrozole

• Product NameLetrozole
  CAS No.112809-51-5
  Purity99% min
  Min Quantity1Kilograms
  Price1~2
• View Contact Detail

• 
  Molecular Structure

Detailed Description

Femara(generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women. Femara is the second in a new class of third-generation selective oral aromatase inhibitors.
It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. Since many forms of breast cancer cells are stimulated by estrogen, it is hoped that by reducing amounts of estrogen in the body the progression of such a disease can be halted. This is the basic premise behind Nolvadex, except this drug blocks the action and not production of estrogen.
• 
• Letrozole